Zap Ultra Tablet is a combination analgesic and anti-inflammatory medication containing Diclofenac 50 mg, Paracetamol 325 mg, and Trypsin Chymotrypsin 50,000 AU. This formulation is designed to provide effective relief from moderate to severe pain associated with musculoskeletal disorders, postoperative inflammation, and soft tissue injuries. Diclofenac, a nonsteroidal anti-inflammatory drug (NSAID), exerts its effect by inhibiting cyclooxygenase enzymes, thereby reducing the synthesis of prostaglandins responsible for pain and inflammation. Paracetamol acts centrally to alleviate pain and reduce fever through inhibition of prostaglandin synthesis in the central nervous system. Trypsin Chymotrypsin, a proteolytic enzyme combination, facilitates the breakdown of protein-based inflammatory exudates, promoting faster resolution of inflammation and edema. The synergistic action of these components results in enhanced analgesic and anti-inflammatory effects, making Zap Ultra Tablet suitable for conditions such as osteoarthritis, rheumatoid arthritis, sprains, strains, and postoperative pain management. It should be used under medical supervision, considering contraindications like hypersensitivity to NSAIDs, active gastrointestinal ulcers, or bleeding disorders. Caution is advised in patients with hepatic or renal impairment. The recommended dosage and duration of therapy should be strictly followed to minimize adverse effects and ensure optimal therapeutic outcomes.